Nuvation Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	42.65	101.1	132.42	29.76	3.47
Short-Term Investments	568.56	559.92	632.97	186	115.4
Cash & Cash Equivalents	611.21	661.01	765.39	215.75	118.87
Cash Growth	-7.53%	-13.64%	254.76%	81.50%	-
Other Current Assets	5.22	6.3	6.68	4.93	1.02
Total Current Assets	616.43	667.32	772.07	220.68	119.89
Property, Plant & Equipment	4.32	4.69	3.66	0.69	0.65
Other Long-Term Assets	0.73	0.14	0.42	0.42	0.42
Total Long-Term Assets	5.05	4.82	4.08	1.11	1.07
Total Assets	621.48	672.14	776.15	221.79	120.95
Accounts Payable	2.21	2.14	3.93	2.17	2.03
Current Debt	1.97	1.21	0.86	0	0
Other Current Liabilities	9.79	9.82	12.14	4.38	1.17
Total Current Liabilities	13.97	13.16	16.93	6.55	3.2
Long-Term Debt	2.04	3.05	2.19	0	0
Other Long-Term Liabilities	0.35	0.85	11.04	0.16	0
Total Long-Term Liabilities	2.39	3.9	13.23	0.16	0
Total Liabilities	16.36	17.07	30.15	6.71	3.2
Total Debt	4.01	4.26	3.06	0	0
Debt Growth	-5.94%	39.44%	-	-	-
Retained Earnings	-342.8	-267	-162.8	-75.96	-34.3
Comprehensive Income	0.18	-5.53	-1.19	1.56	0.42
Shareholders' Equity	605.12	655.08	746	215.08	-24.12
Net Cash / Debt	607.21	656.75	762.34	215.75	118.87
Net Cash / Debt Growth	-7.54%	-13.85%	253.34%	81.50%	-
Net Cash Per Share	2.77	3.03	3.85	2.21	0.58
Working Capital	602.46	654.16	755.15	214.13	116.68
Book Value Per Share	2.77	3.02	3.77	2.21	-0.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).